Form 4: West Pharmaceutical Services SVP, Chief Technology Officer Silji Abraham Reports Stock Sale
SEC Form 4 Filing
Silji Abraham, SVP and Chief Technology Officer of West Pharmaceutical Services, reported selling 1,800 shares of common stock at a price of $330.78 on June 12, 2024.
Summary
- On June 12, 2024, Silji Abraham, the SVP, Chief Technology Officer of West Pharmaceutical Services Inc. (WST), sold 1,800 shares of common stock.
- The transaction was executed at a price of $330.78 per share.
- Following the transaction, Abraham directly owns 2,860.258 shares of West Pharmaceutical Services Inc.
- A Power of Attorney document was filed, granting Luis Cantarero, Louis Lalli, Ryan Metz, and Caitlin Hippeli the authority to execute SEC filings on Abraham's behalf.
Sentiment
Score: 5
Explanation: Neutral sentiment as it is a standard SEC filing reporting a stock sale by an officer. No indication of positive or negative outlook.
Industry Context
This is a routine disclosure of a transaction by a company insider, which is common and required by the SEC to ensure transparency and prevent insider trading.
Stakeholder Impact
- The stock sale by an officer could be perceived neutrally or slightly negatively by shareholders, depending on the context and reasons for the sale.
Key Dates
| Date | Description |
|---|---|
| May 15, 2024 | Date of execution for the Limited Power of Attorney. |
| June 12, 2024 | Date of the stock sale transaction. |
| June 13, 2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.